Generation of profound anti-tumor immunity by AUR-109, a spectrum-selective tyrosine kinase inhibitor, either as a single agent or in combination with immune checkpoint inhibitors

AUR-109 - Orion Corp, Dr. Reddy’s

https://www.abstractsonline.com/pp8/#!/10828/presentation/6738

Girish Daginakatte; Saravanan Thiyagarajan; Kiran Aithal; Mamon Dey; Reshma Reghu; Monalisha Mandal; Kavitha Nellore; Susanta Samajdar; Murali Ramachandra

Mar 14, 2023